Differential Effects of Race, Socioeconomic Status, and Insurance on Disease-Specific Survival in Rectal Cancer

被引:3
|
作者
Del Rosario, Michael [1 ,5 ]
Chang, Jenny [2 ]
Ziogas, Argyrios [2 ]
Clair, Kiran [3 ]
Bristow, Robert E. [3 ]
Tanjasiri, Sora P. [2 ,4 ]
Zell, Jason A. [1 ,2 ,4 ]
机构
[1] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA USA
[3] Univ Calif Irvine, Dept Obstet & Gynecol, Div Gynecol Oncol, Irvine, CA USA
[4] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA
[5] UCI Hlth, Dept Med, Div Hematol Oncol, 101 City Dr South, Bldg 55, Suite 221, Orange, CA 92868 USA
关键词
Health care disparities; National Comprehensive Cancer Network guideline adherence; Rectal cancer; TREATMENT GUIDELINES; BREAST-CANCER; UNITED-STATES; COLON-CANCER; STAGE-II; ASSOCIATION; ADHERENCE; CARE; DISPARITIES; CALIFORNIA;
D O I
10.1097/DCR.0000000000002341
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: National Comprehensive Cancer Network guideline adherence improves cancer outcomes. In rectal cancer, guideline adherence is distributed differently by race/ethnicity, socioeconomic status, and insurance. OBJECTIVE: This study aimed to determine the independent effects of race/ethnicity, socioeconomic status, and insurance status on rectal cancer survival after accounting for differences in guideline adherence. DESIGN: This was a retrospective study. SETTINGS: The study was conducted using the California Cancer Registry. PATIENTS: This study included patients aged 18 to 79 years diagnosed with rectal adenocarcinoma between January 1, 2004, and December 31, 2017, with follow-up through November 30, 2018. Investigators determined whether patients received guideline-adherent care. MAIN OUTCOME MEASURES: ORs and 95% CIs were used for logistic regression to analyze patients receiving guideline-adherent care. Disease-specific survival analysis was calculated using Cox regression models. RESULTS: A total of 30,118 patients were examined. Factors associated with higher odds of guideline adherence included Asian and Hispanic race/ethnicity, managed care insurance, and high socioeconomic status. Asians (HR, 0.80; 95% CI, 0.72-0.88; p < 0.001) and Hispanics (HR, 0.91; 95% CI, 0.83-0.99; p = 0.0279) had better disease-specific survival in the nonadherent group. Race/ethnicity were not factors associated with disease-specific survival in the guideline adherent group. Medicaid disease-specific survival was worse in both the nonadherent group (HR, 1.56; 95% CI, 1.40-1.73; p < 0.0001) and the guideline-adherent group (HR, 1.18; 95% CI, 1.08-1.30; p = 0.0005). Disease-specific survival of the lowest socioeconomic status was worse in both the nonadherent group (HR, 1.42; 95% CI, 1.27-1.59) and the guideline-adherent group (HR, 1.20; 95% CI, 1.08-1.34). LIMITATIONS: Limitations included unmeasured confounders and the retrospective nature of the review. CONCLUSIONS: Race, socioeconomic status, and insurance are associated with guideline adherence in rectal cancer. Race/ethnicity was not associated with differences in disease-specific survival in the guideline-adherent group. Medicaid and lowest socioeconomic status had worse disease-specific survival in both the guideline nonadherent group and the guideline-adherent group. See Video Abstract at http://links.lww.com/DCR/ B954.
引用
下载
收藏
页码:1263 / 1272
页数:10
相关论文
共 50 条
  • [1] Impact of Race, Ethnicity, and Socioeconomic Status on Nasopharyngeal Carcinoma Disease-Specific and Conditional Survival
    London, Ashley O.
    Gallagher, Liam W.
    Sharma, Rahul K.
    Spielman, Daniel
    Golub, Justin S.
    Overdevest, Jonathan B.
    Yan, Carol H.
    DeConde, Adam
    Gudis, David A.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2022, 83 (05) : 451 - 460
  • [2] Impact of Socioeconomic Status on Paranasal Sinus Cancer Disease-Specific and Conditional Survival
    Sharma, Rahul K.
    Del Signore, Anthony
    Govindaraj, Satish
    Iloreta, Alfred
    Overdevest, Jonathan B.
    Gudis, David A.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2022, 166 (06) : 1070 - 1077
  • [3] Does Insurance Status Impact Disease-Specific Survival of Appendiceal Neoplasms?
    Pu, Tracey
    Gaitanidis, Apostolos
    Feliberti, Eric
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 469 - 469
  • [4] Effects of race and socioeconomic status on survival of women with breast cancer
    Blake Cady
    Annals of Surgical Oncology, 1997, 4 : 102 - 103
  • [5] Effects of race and socioeconomic status on survival of women with breast cancer
    Cady, B
    ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (02) : 102 - 103
  • [6] Socioeconomic and insurance-related disparities in disease-specific survival among patients with metastatic bone disease
    Jawad, Muhammad Umar
    Pollock, Brad H.
    Wise, Barton L.
    Zeitlinger, Lauren N.
    O' Donnell, Edmond F., III
    Carr-Ascher, Janai R.
    Cizik, Amy
    Ferrell, Betty
    Thorpe, Steven W.
    Randall, R. Lor
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 127 (01) : 159 - 173
  • [7] Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer
    Susrutha Puthanmadhom Narayanan
    Dianxu Ren
    Steffi Oesterreich
    Adrian V. Lee
    Margaret Q. Rosenzweig
    Adam M. Brufsky
    npj Breast Cancer, 9
  • [8] Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer
    Narayanan, Susrutha Puthanmadhom
    Ren, Dianxu
    Oesterreich, Steffi
    Lee, Adrian V.
    Rosenzweig, Margaret Q.
    Brufsky, Adam M.
    NPJ BREAST CANCER, 2023, 9 (01)
  • [9] An Interaction of Race and Ethnicity With Socioeconomic Status in Rectal Cancer Outcomes
    Kim, Joseph
    Artinyan, Avo
    Mailey, Brian
    Christopher, Stefanie
    Lee, Wendy
    McKenzie, Shaun
    Chen, Steven L.
    Bhatia, Smita
    Pigazzi, Alessio
    Garcia-Aguilar, Julio
    ANNALS OF SURGERY, 2011, 253 (04) : 647 - 654
  • [10] Association of race and socioeconomic status and outcomes with patients with rectal cancer
    Nitzkorski, J. R.
    Willis, A. I.
    Farma, J. M.
    Cohen, S. J.
    Zhu, F.
    Nick, D. M.
    Sigurdson, E. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)